Schlagwortarchiv für: Publikationen: Stefaan Van Gool MD. PhD.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-10-24 / Sci Rep 2017 10;7(1):13902
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-10-24 / Sci Rep 2017 10;7(1):139022017-10-24 00:00:002021-11-15 20:01:44Immunotherapy with subcutaneous immunogenic autologous tumor lysate increases murine glioblastoma survival
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-07-19 / Int J Cancer 2017 11;141(9):1891-1900
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-07-19 / Int J Cancer 2017 11;141(9):1891-19002017-07-19 00:00:002021-11-15 20:03:02Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-04-27 / Sci Rep 2017 04;7(1):1217
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-04-27 / Sci Rep 2017 04;7(1):12172017-04-27 00:00:002021-11-15 20:07:45Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-01-21 / J Neurooncol 2017 04;132(2):255-266
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-01-21 / J Neurooncol 2017 04;132(2):255-2662017-01-21 00:00:002021-11-15 20:06:08Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-12 / Cytotherapy 2016 09;18(9):1178-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-12 / Cytotherapy 2016 09;18(9):1178-862016-07-12 00:00:002020-06-23 10:01:20Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-14 / Front Immunol 2015;6:663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-14 / Front Immunol 2015;6:6632016-01-14 00:00:002021-11-15 13:26:00Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e1083669
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-09-11 / Oncoimmunology 2016 Feb;5(2):e10836692015-09-11 00:00:002021-11-15 13:26:23Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-08-27 / Biomed Res Int 2015;2015:842923
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-08-27 / Biomed Res Int 2015;2015:8429232015-08-27 00:00:002021-11-15 13:26:51Tumour Relapse Prediction Using Multiparametric MR Data Recorded during Follow-Up of GBM Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-06-17 / Front Oncol 2015;5:98
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-06-17 / Front Oncol 2015;5:982015-06-17 00:00:002021-11-15 13:27:21Brain Tumor Immunotherapy: What have We Learned so Far?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-06-13 / J. Neurooncol. 2015 Sep;124(2):325-322015-06-13 00:00:002021-11-15 13:28:49Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
